11:10 AM EDT, 07/17/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were lower late Wednesday morning, falling 1.33% to 1,437.22 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by semiconductor company Sequans Communications ( SQNS ) and brewing company Anheuser-Busch InBev ( BUD ) , which were up 2.3% and 2% respectively. They were followed by medical device maker EDAP TMS ( EDAP ) and financial services company ING (ING), which increased 1.6% and 1.4% respectively.

The decliners from continental Europe were led by pharmaceutical company Novo Nordisk ( NVO ) and biotech firm Evaxion Biotech ( EVAX ) , which fell 4.3% and 2.4% respectively. They were followed by travel company trivago (TRVG) and biopharmaceutical company Grifols ( GRFS ) , which dropped 2.3% each.

From the UK and Ireland, the gainers were led by biotech firm Trinity Biotech ( TRIB ) and software company Endava ( DAVA ) , which increased 3.8% and 2.2% respectively. They were followed by medical device maker Smith & Nephew ( SNN ) and pharmaceutical company GSK (GSK), which rose 2.1% each.

The decliners from the UK and Ireland were led by biopharmaceutical firm Biodexa Pharmaceuticals ( BDRX ) and pharmaceutical company Silence Therapeutics ( SLN ) , which lost 4.5% and 3.3% respectively. They were followed by biopharmaceutical companies Mereo BioPharma Group (MREO) and TC Biopharm (TCBP), which were down 3.2% and 2.4% respectively.